Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 37

1.

The Role of Cannabinoid Receptors in the Descending Modulation of Pain.

Palazzo E, Luongo L, Novellis V, Rossi F, Maione S.

Pharmaceuticals (Basel). 2010 Aug 16;3(8):2661-2673. Review.

2.

Endocannabinoids in cerebrovascular regulation.

Benyó Z, Ruisanchez É, Leszl-Ishiguro M, Sándor P, Pacher P.

Am J Physiol Heart Circ Physiol. 2016 Apr 1;310(7):H785-801. doi: 10.1152/ajpheart.00571.2015. Epub 2016 Jan 29. Review.

3.

Vascular Expression of Transient Receptor Potential Vanilloid 1 (TRPV1).

Sand CA, Grant AD, Nandi M.

J Histochem Cytochem. 2015 Jun;63(6):449-53. doi: 10.1369/0022155415581014. Epub 2015 Mar 25. No abstract available.

4.

Role of TRP channels in the cardiovascular system.

Yue Z, Xie J, Yu AS, Stock J, Du J, Yue L.

Am J Physiol Heart Circ Physiol. 2015 Feb 1;308(3):H157-82. doi: 10.1152/ajpheart.00457.2014. Epub 2014 Nov 21. Review.

5.

Role of endocannabinoids and cannabinoid-1 receptors in cerebrocortical blood flow regulation.

Iring A, Ruisanchez É, Leszl-Ishiguro M, Horváth B, Benkő R, Lacza Z, Járai Z, Sándor P, Di Marzo V, Pacher P, Benyó Z.

PLoS One. 2013;8(1):e53390. doi: 10.1371/journal.pone.0053390. Epub 2013 Jan 4.

6.

Update on vascular endothelial Ca(2+) signalling: A tale of ion channels, pumps and transporters.

Moccia F, Berra-Romani R, Tanzi F.

World J Biol Chem. 2012 Jul 26;3(7):127-58. doi: 10.4331/wjbc.v3.i7.127.

7.

Triphasic blood pressure responses to cannabinoids: do we understand the mechanism?

Malinowska B, Baranowska-Kuczko M, Schlicker E.

Br J Pharmacol. 2012 Apr;165(7):2073-88. doi: 10.1111/j.1476-5381.2011.01747.x. Review.

8.

Intrathecal injection of TRPV1 shRNA leads to increases in blood pressure in rats.

Yu SQ, Wang DH.

Acta Physiol (Oxf). 2011 Sep;203(1):139-47. doi: 10.1111/j.1748-1716.2011.02285.x. Epub 2011 Apr 22.

9.

Phenotyping cardiac gene therapy in mice.

Bostick B, Yue Y, Duan D.

Methods Mol Biol. 2011;709:91-104. doi: 10.1007/978-1-61737-982-6_6.

10.

Emerging concepts for the role of TRP channels in the cardiovascular system.

Vennekens R.

J Physiol. 2011 Apr 1;589(Pt 7):1527-34. doi: 10.1113/jphysiol.2010.202077. Epub 2010 Dec 20. Review.

11.

Fatty acid amide hydrolase is a key regulator of endocannabinoid-induced myocardial tissue injury.

Mukhopadhyay P, Horváth B, Rajesh M, Matsumoto S, Saito K, Bátkai S, Patel V, Tanchian G, Gao RY, Cravatt BF, Haskó G, Pacher P.

Free Radic Biol Med. 2011 Jan 1;50(1):179-95. doi: 10.1016/j.freeradbiomed.2010.11.002. Epub 2010 Nov 9.

12.

TRPV channels and vascular function.

Baylie RL, Brayden JE.

Acta Physiol (Oxf). 2011 Sep;203(1):99-116. doi: 10.1111/j.1748-1716.2010.02217.x. Epub 2010 Dec 9. Review.

13.

Increased susceptibility to cardiovascular effects of dihydrocapcaicin in resuscitated rats. Cardiovascular effects of dihydrocapsaicin.

Fosgerau K, Ristagno G, Jayatissa M, Axelsen M, Gotfredsen JW, Weber UJ, Køber L, Torp-Pedersen C, Videbaek C.

BMC Cardiovasc Disord. 2010 Aug 31;10:39. doi: 10.1186/1471-2261-10-39.

14.

Increased catecholamine secretion contributes to hypertension in TRPM4-deficient mice.

Mathar I, Vennekens R, Meissner M, Kees F, Van der Mieren G, Camacho Londoño JE, Uhl S, Voets T, Hummel B, van den Bergh A, Herijgers P, Nilius B, Flockerzi V, Schweda F, Freichel M.

J Clin Invest. 2010 Sep;120(9):3267-79. doi: 10.1172/JCI41348. Epub 2010 Aug 2.

15.

Activation of TRPV1 by dietary capsaicin improves endothelium-dependent vasorelaxation and prevents hypertension.

Yang D, Luo Z, Ma S, Wong WT, Ma L, Zhong J, He H, Zhao Z, Cao T, Yan Z, Liu D, Arendshorst WJ, Huang Y, Tepel M, Zhu Z.

Cell Metab. 2010 Aug 4;12(2):130-41. doi: 10.1016/j.cmet.2010.05.015.

16.

A cannabinoid receptor, sensitive to O-1918, is involved in the delayed hypotension induced by anandamide in anaesthetized rats.

Zakrzeska A, Schlicker E, Baranowska M, Kozłowska H, Kwolek G, Malinowska B.

Br J Pharmacol. 2010 Jun;160(3):574-84. doi: 10.1111/j.1476-5381.2009.00579.x. Epub 2010 Jan 25.

17.

Factors influencing the regional haemodynamic responses to methanandamide and anandamide in conscious rats.

Gardiner SM, March JE, Kemp PA, Bennett T.

Br J Pharmacol. 2009 Oct;158(4):1143-52. doi: 10.1111/j.1476-5381.2009.00363.x. Epub 2009 Aug 20.

18.

Endocannabinoids and cardiac contractile function: pathophysiological implications.

Bátkai S, Pacher P.

Pharmacol Res. 2009 Aug;60(2):99-106. Review.

19.

The emerging role of the endocannabinoid system in cardiovascular disease.

Pacher P, Steffens S.

Semin Immunopathol. 2009 Jun;31(1):63-77. doi: 10.1007/s00281-009-0145-8. Epub 2009 Apr 9. Review.

20.

Endocannabinoids and the heart.

Hiley CR.

J Cardiovasc Pharmacol. 2009 Apr;53(4):267-76. doi: 10.1097/FJC.0b013e318192671d. Review.

Supplemental Content

Support Center